Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 01 Feb 2022 07:00 CET |
TARGOVAX | Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration | 20103010 Biotechnology | Non-regulatory press releases |
| 17 Jan 2022 07:00 CET |
TARGOVAX | Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Jan 2022 11:50 CET |
TARGOVAX | Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway | 20103010 Biotechnology | Inside information |
| 29 Dec 2021 08:48 CET |
TARGOVAX | Notification of changed shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 23 Dec 2021 22:46 CET |
TARGOVAX | Targovax ASA issues options to employees | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 Dec 2021 08:08 CET |
TARGOVAX | NOTICE OF CHANGED SHAREHOLDING | 20103010 Biotechnology | Major shareholding notifications |
| 22 Dec 2021 19:55 CET |
TARGOVAX | NOTICE OF CHANGED SHAREHOLDING | 20103010 Biotechnology | Major shareholding notifications |
| 22 Dec 2021 08:57 CET |
TARGOVAX | Targovax ASA - Registration of share capital increase pertaining to the Rights Issue | 20103010 Biotechnology | Total number of voting rights and capital |
| 20 Dec 2021 07:51 CET |
TARGOVAX | Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Dec 2021 13:15 CET |
TARGOVAX | Targovax ASA: Primary insider share purchase | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 16 Dec 2021 10:13 CET |
TARGOVAX | Targovax ASA: Primary insiders share purchase | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 16 Dec 2021 09:56 CET |
TARGOVAX | Targovax ASA: Primary insiders share purchase | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Dec 2021 17:37 CET |
TARGOVAX | Targovax awarded NOK 9.8m research grant by the Research Council of Norway towards the TG mutant RAS program | 20103010 Biotechnology | Inside information |
| 15 Dec 2021 13:16 CET |
TARGOVAX | Targovax ASA - Final results of the rights issue | 20103010 Biotechnology | Inside information |
| 14 Dec 2021 18:20 CET |
TARGOVAX | Targovax ASA - Preliminary results of the rights issue | 20103010 Biotechnology | Inside information |
| 14 Dec 2021 07:00 CET |
TARGOVAX | Targovax ASA - The subscription period for the rights issue expires today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2021 07:00 CET |
TARGOVAX | Targovax to present at DNB's 12[th] Nordic Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 10 Dec 2021 11:21 CET |
TARGOVAX | Targovax ASA - Exercise of subscription rights in the rights issue by close associate of a primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Dec 2021 07:00 CET |
TARGOVAX | Targovax ASA - Last day of trading in subscription rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Dec 2021 06:56 CET |
TARGOVAX | Targovax ASA - Exercise of subscription rights in the rights issue by close associate of a primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 05 Dec 2021 20:45 CET |
TARGOVAX | Shareholder disclosure by Radforsk Investeringsstiftelse | 20103010 Biotechnology | Major shareholding notifications |
| 03 Dec 2021 08:08 CET |
TARGOVAX | Disclosure in Targovax ASA | 20103010 Biotechnology | Major shareholding notifications |
| 02 Dec 2021 08:21 CET |
TARGOVAX | Disclosure in TARGOVAX ASA | 20103010 Biotechnology | Major shareholding notifications |
| 01 Dec 2021 13:43 CET |
TARGOVAX | Targovax ASA - Exercise of subscription rights in the rights issue by close associate of a primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Nov 2021 15:40 CET |
TARGOVAX | Targovax ASA - Exercise of subscription rights in the rights issue by close associate of a primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Nov 2021 15:13 CET |
TARGOVAX | Targovax ASA - Receipt of subscription rights in the rights issue by primary insiders and their close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Nov 2021 07:00 CET |
TARGOVAX | Targovax ASA - Commencement of the subscription period for the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Nov 2021 13:24 CET |
TARGOVAX | Targovax ASA - Approval and publication of the prospectus for the rights issue | 20103010 Biotechnology | Prospectus / admission document |
| 26 Nov 2021 07:00 CET |
TARGOVAX | TRVX - Ex. subscription rights today | 20103010 Biotechnology | Ex Date |
| 25 Nov 2021 09:36 CET |
TARGOVAX | Targovax ASA - Rights issue approved by the extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Nov 2021 19:07 CET |
TARGOVAX | Targovax ASA - Updated key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Nov 2021 19:04 CET |
TARGOVAX | Targovax ASA - Terms of the fully underwritten rights issue | 20103010 Biotechnology | Inside information |
| 18 Nov 2021 07:00 CET |
TARGOVAX | Targovax invites to webcast presentation in Norwegian | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Nov 2021 12:25 CET |
TARGOVAX | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Nov 2021 12:25 CET |
TARGOVAX | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 09 Nov 2021 14:00 CET |
TARGOVAX | Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Nov 2021 07:04 CET |
TARGOVAX | Targovax ASA - Key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2021 07:02 CET |
TARGOVAX | Targovax ASA - Notice of extraordinary general meeting - Fully underwritten rights issue | 20103010 Biotechnology | Inside information |
| 04 Nov 2021 07:00 CET |
TARGOVAX | Targovax ASA: Third quarter 2021 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 27 Oct 2021 09:34 CEST |
TARGOVAX | Targovax ASA: PDMR notices | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 27 Oct 2021 07:00 CEST |
TARGOVAX | Targovax ASA: Invitation to presentation of Targovax's third quarter 2021 results, Thursday 4 November | 20103010 Biotechnology | Non-regulatory press releases |
| 25 Oct 2021 13:30 CEST |
TARGOVAX | Targovax: Presentation material for today's webcast | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Oct 2021 14:35 CEST |
TARGOVAX | Targovax invites to webcast presentation on Xtrainvestor | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Oct 2021 11:39 CEST |
TARGOVAX | Targovax ASA: GRANT OF SHARE OPTIONS | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 20 Oct 2021 08:30 CEST |
TARGOVAX | Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO | 20103010 Biotechnology | Inside information |
| 19 Oct 2021 14:04 CEST |
TARGOVAX | Targovax to present at upcoming conferences | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Oct 2021 14:27 CEST |
TARGOVAX | Targovax ASA: Two abstracts accepted at the SITC Congress | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Oct 2021 18:44 CEST |
TARGOVAX | Targovax ASA issues options to new member of management | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Sep 2021 07:00 CEST |
TARGOVAX | Targovax ASA appoints Ola Melin as Head of Manufacturing | 20103010 Biotechnology | Non-regulatory press releases |
| 24 Sep 2021 10:57 CEST |
TARGOVAX | Targovax granted European Patent for ONCOS-102 in combination with chemotherapy | 20103010 Biotechnology | Non-regulatory press releases |